SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Intensive Care Medicine
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rivers, E. P.
Right arrow Articles by Loomba, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivers, E. P.
Right arrow Articles by Loomba, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Sepsis
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical Utility of B-Type Natriuretic Peptide in Early Severe Sepsis and Septic Shock

Emanuel P. Rivers, MD, MPH

Department of Emergency Medicine, Henry Ford Hospital, Wayne State University, Detroit, Michigan, Department of Surgery, Henry Ford Hospital, Wayne State University, Detroit, Michigan, erivers1{at}hfhs.org

James McCord, MD

Department of Cardiology, Henry Ford Hospital, Wayne State University, Detroit, Michigan

Ronny Otero, MD

Department of Emergency Medicine, Henry Ford Hospital, Wayne State University, Detroit, Michigan

Gordon Jacobsen, MS

Department of Biostatistics and Epidemiology (GJ), Henry Ford Hospital, Wayne State University, Detroit, Michigan

Manisha Loomba, MD

Department of Anesthesiology, Henry Ford Hospital, Wayne State University Detroit, Michigan

B-type natriuretic peptide (BNP) has diagnostic, therapeutic, and prognostic utility in critically ill patients. For severe sepsis and septic shock patients in particular, similar clinical utility from the most proximal aspects of hospital presentation to the intensive care unit has not been examined. BNP levels were measured at 0, 3, 6, 12, 24, 36, 48, 60, and 72 hours in 252 patients presenting to the emergency department with severe sepsis and septic shock. The clinicians were blinded to the BNP levels. Elevated BNP levels (>100 pg/mL) were seen in 42% and 69% of patients on presentation and at 24 hours, respectively. Elevated BNP ranges (>230 pg/mL) were significantly associated with myocardial dysfunction and severity of global tissue hypoxia. When adjusted for age, gender, history of heart failure, renal function, organ dysfunction, and mean arterial pressure, a BNP greater than 210 pg/mL at 24 hours was the most significant independent indicator of increased mortality: odds ratio 1.061 (1.026-1.097), P < .001, 95% confidence interval. Patients with severe sepsis and septic shock often have elevated BNP levels, which are significantly associated with organ and myocardial dysfunction, global tissue hypoxia, and mortality. Serial BNP levels may be a useful adjunct in the early detection, stratification, treatment, and prognostication of high-risk patients.

Key Words: B-type natriuretic peptide • sepsis • severe sepsis • septic shock • myocardial dysfunction • global tissue hypoxia • organ dysfunction • critical illness

References

  • Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin. 2001;19:557-571.[CrossRef][Medline] [Order article via Infotrieve]
  • Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126-1130.[CrossRef][Medline] [Order article via Infotrieve]
  • Phua J., Lim TK, Lee KH B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005;33:2094-2013.[CrossRef][Medline] [Order article via Infotrieve]
  • Hoffmann U., Brueckmann M., Bertsch T., et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab. 2005;51: 373-379.[Medline] [Order article via Infotrieve]
  • Cuthbertson BH, Patel RR, Croal BL, Barclay J., Hillis GS B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia. 2005;60:16-21.[CrossRef][Medline] [Order article via Infotrieve]
  • Charpentier J., Luyt CE, Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004;32:660-665.[CrossRef][Medline] [Order article via Infotrieve]
  • Tung RH, Garcia C., Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med. 2004;32:1643-1647.[CrossRef][Medline] [Order article via Infotrieve]
  • Berendes E., Van Aken H., Raufhake C., Schmidt C., Assmann G., Walter M. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg. 2001;93:676-682.[Abstract/Free Full Text]
  • McLean AS, Huang SJ The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care. 2005;11:406-412.[CrossRef][Medline] [Order article via Infotrieve]
  • Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.[Abstract/Free Full Text]
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.[Medline] [Order article via Infotrieve]
  • Le Gall JR, Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study [published correction appears in JAMA. 1994;271:1321]. JAMA. 1993;270:2957-2963.[Abstract/Free Full Text]
  • Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638-1652.[CrossRef][Medline] [Order article via Infotrieve]
  • Aduen J., Bernstein WK, Khastgir T., et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994;272:1678-1685.[Abstract/Free Full Text]
  • Varpula M., Tallgren M., Saukkonen K., Voipio-Pulkki LM, Pettila V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005;31:1066-1071.[CrossRef][Medline] [Order article via Infotrieve]
  • Silance PG, Vincent JL Oxygen extraction in patients with sepsis and heart failure: another look at clinical studies. Clin Intensive Care. 1994;5:4-14.[Medline] [Order article via Infotrieve]
  • Kasnitz P., Druger GL, Yorra F., Simmons DH Mixed venous oxygen tension and hyperlactatemia: survival in severe cardiopulmonary disease. JAMA. 1976;236:570-574.[Abstract/Free Full Text]
  • Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE APACHE—acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591-597.[Medline] [Order article via Infotrieve]
  • Maisel AS, Krishnaswamy P., Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.[Abstract/Free Full Text]
  • McCullough PA, Nowak RM, McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.[Abstract/Free Full Text]
  • Estenssoro E., Gonzalez F., Laffaire E., et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest. 2005;127:598-603.[Abstract/Free Full Text]
  • Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 1995; 274:968-974.[Abstract/Free Full Text]
  • Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005;33:2194-2201.[CrossRef][Medline] [Order article via Infotrieve]
  • Parrillo JE Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Int J Cardiol. 1985;7:314-321.[CrossRef][Medline] [Order article via Infotrieve]
  • Parrillo JE, Burch C., Shelhamer JH, Parker MM, Natanson C., Schuette W. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985;76:1539-1553.[Medline] [Order article via Infotrieve]
  • Astiz ME, Rackow EC, Kaufman B., Falk JL, Weil MH Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988;16:655-658.[Medline] [Order article via Infotrieve]
  • Karimova A., Pinsky DJ The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med. 2001;27:19-31.[CrossRef][Medline] [Order article via Infotrieve]
  • Astiz ME, Rackow EC, Weil MH Oxygen delivery and utilization during rapidly fatal septic shock in rats. Circ Shock. 1986;20:281-290.[Medline] [Order article via Infotrieve]
  • Fink MP Bench-to-bedside review: cytopathic hypoxia. Crit Care. 2002;6:491-499.[CrossRef][Medline] [Order article via Infotrieve]
  • de Denus S., Pharand C., Williamson DR Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest. 2004;125:652-668.[Abstract/Free Full Text]
  • Mitaka C., Hirata Y., Nagura T., Tsunoda Y., Itoh M., Amaha K. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care. 1997; 12:66-71.[CrossRef][Medline] [Order article via Infotrieve]
  • Vieillard-Baron A., Schmitt JM, Augarde R., et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001;29:1551-1555.[CrossRef][Medline] [Order article via Infotrieve]
  • Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, Duff JH Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest. 1978;73:583-591.[Abstract/Free Full Text]
  • Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH Oxygen delivery and consumption in patients with hyper-dynamic septic shock. Crit Care Med. 1987;15:26-28.[Medline] [Order article via Infotrieve]
  • Hopkins WE, Chen Z., Fukagawa NK, Hall C., Knot HJ, LeWinter MM Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004;109:2872-2877.[Abstract/Free Full Text]
  • Zhang Y., Oliver JR, Horowitz JD The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release. J Cardiovasc Pharmacol. 2004;43:227-233.[CrossRef][Medline] [Order article via Infotrieve]
  • Nakanishi K., Tajima F., Itoh H., et al. Changes in atrial natriuretic peptide and brain natriuretic peptide associated with hypobaric hypoxia-induced pulmonary hypertension in rats. Virchows Arch. 2001;439:808-817.[Medline] [Order article via Infotrieve]
  • Sun JZ, Chen SJ, Li G., Chen YF Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice. Am J Physiol Lung Cell Mol Physiol. 2000;279:L511-L519.[Abstract/Free Full Text]
  • Goetze JP, Gore A., Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB Acute myocardial hypoxia increases BNP gene expression. Faseb J. 2004;18:1928-1930.[Abstract/Free Full Text]
  • Padilla F., Garcia-Dorado D., Agullo L., et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res. 2001;51:592-600.[Abstract/Free Full Text]
  • Torre-Amione G., Kapadia S., Benedict C., Oral H., Young JB, Mann DL Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206.[Abstract]
  • Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003;29:1696-1702.[CrossRef][Medline] [Order article via Infotrieve]
  • Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31: 391-398.[Abstract/Free Full Text]
  • Ueland T., Kjekshus J., Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46: 2018-2021.[Abstract/Free Full Text]
  • He Q., LaPointe MC Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension. 1999;33:283-289.[Abstract/Free Full Text]
  • MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 1997;79:1128-1131.[CrossRef][Medline] [Order article via Infotrieve]
  • Tomaru Ki K., Arai M., Yokoyama T., et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2002;34:649-659.[CrossRef][Medline] [Order article via Infotrieve]
  • McLean AS, Huang SJ, Nalos M., Tang B., Stewart DE The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med. 2003;31:2611-2618.[CrossRef][Medline] [Order article via Infotrieve]
  • Ueda R., Yokouchi M., Suzuki T., Otomo E., Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med. 2003; 114:266-270.[CrossRef][Medline] [Order article via Infotrieve]
  • Alboni P., Brignole M., Menozzi C., Scarfo S. Is sinus bradycardia a factor facilitating overt heart failure? Eur Heart J. 1999;20:252-255.[Free Full Text]
  • Thomas JT, Kelly RF, Thomas SJ, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med. 2002; 112:437-445.[CrossRef][Medline] [Order article via Infotrieve]
  • Jefic D., Lee JW, Jefic D., Savoy-Moore RT, Rosman HS Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest. 2005;128:288-295.[Abstract/Free Full Text]
  • Ander DS, Jaggi M., Rivers E., et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol. 1998;82:888-891.[CrossRef][Medline] [Order article via Infotrieve]
  • Trzeciak S., Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest. 2006;129:225-232.[Abstract/Free Full Text]
  • Brueckmann M., Huhle G., Lang S., et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005;112:527-534.[Abstract/Free Full Text]
  • Roch A., Allardet-Servent J., Michelet P., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med. 2005;33:1001-1007.[CrossRef][Medline] [Order article via Infotrieve]
  • Hollenberg SM, Ahrens TS, Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928-1948.[CrossRef]
  • Mendoza A., Kim YN, Chernoff A. Hypoglycemia in hospitalized adult patients without diabetes. Endocr Pract. 2005;11:91-96.[Medline] [Order article via Infotrieve]
  • Fischer KF, Lees JA, Newman JH Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med. 1986; 315:1245-1250.[Abstract]
  • Shilo S., Berezovsky S., Friedlander Y., Sonnenblick M. Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc. 1998;46:978-982.[Medline] [Order article via Infotrieve]
  • Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am. 1989;18:103-121.[Medline] [Order article via Infotrieve]
  • McCullough PA, Sandberg KR B-type natriuretic peptide and renal disease. Heart Fail Rev. 2003;8:355-358.[CrossRef][Medline] [Order article via Infotrieve]
  • Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7:21-29.[CrossRef][Medline] [Order article via Infotrieve]
  • Squara P., Bennett D., Perret C. Pulmonary artery catheter: does the problem lie in the users? Chest. 2002;121:2009-2015.[Abstract/Free Full Text]
  • Mehta RL, Pascual MT, Soroko S., Chertow GM Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547-2553.[Abstract/Free Full Text]

Journal of Intensive Care Medicine, Vol. 22, No. 6, 363-373 (2007)
DOI: 10.1177/0885066607307523
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
M. Y. Rady
B-Type Natriuretic Peptide and Sepsis: It Is Not Just the Heart
J Intensive Care Med, November 1, 2007; 22(6): 386 - 388.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rivers, E. P.
Right arrow Articles by Loomba, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivers, E. P.
Right arrow Articles by Loomba, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Sepsis
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement